[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355097-105":59,"doc-detail-355097-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-kansl1-arl17a-fusion-gene-generates-oncogenic-chkansarl-and-f-circka-rnas-that-synergistically-drive-lung-cancer-progression-via-a-novel-f-circkamir-6860chkansarl-axis-research-article","The KANSL1-ARL17A fusion gene generates oncogenic chKANSARL and F-circKA RNAs that synergistically drive lung cancer progression via a novel F-circKA/miR-6860/chKANSARL axis - Research article","","Fusion genes produce oncogenic chimeric RNAs and fusion circular RNAs, yet how they cooperate during tumor progression remains unclear. This study identifies a lung cancer-specific chimeric RNA, KANSL1-ARL17A (chKANSARL), and its circular counterpart, F-circKA, both derived from KANSARL. Overexpression increases proliferation, migration, invasion, and in vivo tumor growth, whereas knockdown suppresses malignancy. Mechanistically, F-circKA sponges miR-6860 to derepress chKANSARL, and miR-6860 inhibition rescues the phenotype, defining an F-circKA/miR-6860/chKANSARL axis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-kansl1-arl17a-fusion-gene-generates-oncogenic-chkansarl-and-f-circka-rnas-that-synergistically-drive-lung-cancer-progression-via-a-novel-f-circkamir-6860chkansarl-axis-research-article/355097/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-kansl1-arl17a-fusion-gene-generates-oncogenic-chkansarl-and-f-circka-rnas-that-synergistically-drive-lung-cancer-progression-via-a-novel-f-circkamir-6860chkansarl-axis-research-article/355097.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What fusion-derived RNAs were identified in this study?","Question",{"text":112,"@type":113},"The study identifies a lung cancer-specific chimeric RNA, chKANSARL, and a circular variant, F-circKA, both derived from the KANSL1-ARL17A fusion gene.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do chKANSARL and F-circKA affect lung cancer cells?",{"text":117,"@type":113},"Overexpression of either transcript enhances lung cancer cell proliferation, migration, and invasion, while knockdown suppresses these malignant phenotypes.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links F-circKA to chKANSARL expression?",{"text":121,"@type":113},"miRNA sequencing and dual-luciferase assays show that F-circKA acts as a sponge for miR-6860, derepressing chKANSARL expression; inhibiting miR-6860 reverses the tumor-suppressive effect of F-circKA knockdown.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355097,1791075281,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","RESEARCH ARTICLE  \nThe KANSL1-ARL17A fusion gene generates oncogenicchKANSARL and F-circKA RNAs that synergistically drive lung cancer progression via a novel F-circKA/miR-6860/ chKANSARL axis  \nReceived for publication, June 13, 2025, and in revised form, December 9, 2025 Published, Papers in Press, January 20, 2026 [https://doi.org/10.1016/j.jbc.2026.1](https://doi.org/10.1016/j.jbc.2026.1)11170  \nXinchao Guan 1,‡, Tao Liu 1,‡, Sili Chen1,‡, Junwei Zhang1, Huanliang Huang2, Dexiong Chen2, and  \nQiaoyuan Yang1,2,*  \nFrom the 1The Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, Guangzhou, China; 2Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China  \nReviewed by members of the JBC Editorial Board. Edited by Paul Shapiro  \nFusion genes are pivotal drivers of tumorigenesis, often generating oncogenic chimeric RNAs and fusion circular RNAs. However, the mechanisms by which these transcripts synergistically contribute to cancer progression remain poorly understood. Here, we identified a lung cancer-specific chimeric RNA KANSL1-ARL17A (chKANSARL) and its circular variant fusion circular RNA KANSL1-ARL17 A (F-circKA), both derived from the fusion gene KANSARL. Functional assays revealed that overexpression of either chKANSARL or F-circKA significantly enhanced lung cancer cell proliferation, migration, and invasion, while their knockdown suppressed these malignant phenotypes. In vivo experiments demonstrated that chKANSARL overexpression accelerated tumor growth in immunodeficient mice. Notably, coexpression experiments uncovered a synergistic regulatory interaction between F-circKA and chKANSARL, amplifying oncogenic effects. Mechanistically, miRNA sequencing and dual-luciferase assays revealed that F-circKA acts as a molecular sponge for miR-6860, thereby derepressing chKANSARL expression. Rescue experiments further validated this regulatory axis, wherein miR-6860 inhibition reversed the tumorsuppressive effects of F-circKA knockdown. Collectively, our study identifies and characterizes a novel F-circKA/miR-6860/ chKANSARL regulatory axis, revealing how dual transcriptional outputs from the KANSARL fusion gene can synergistically drive lung cancer progression. These findings highlight a previously unrecognized layer of cooperative regulation between linear and circular fusion RNAs in oncogenesis and provide a new framework for understanding fusion genemediated tumorigenesis.  \nLung cancer remains one of the most lethal malignancies worldwide, accounting for over 1.8 million deaths annually and posing a significant public health burden (1). While risk  \n‡ These authors contributed equally to this work.  \n* For correspondence: Qiaoyuan Yang, [qiaoyuan_yang@gzhmu.edu.cn](qiaoyuan_yang@gzhmu.edu.cn).  \nfactors such as smoking, environmental carcinogens, and chronic inflammation contribute to its pathogenesis, genomic instability—a hallmark of cancer—plays a central role in driving oncogenic transformations (2–5). Chromosomal rearrangements, including translocations, deletions, and inversions, frequently generate fusion genes that disrupt normal cellular regulation. These aberrations often produce chimeric RNAs (chRNAs) or fusion circular RNAs (F-circRNAs), which serve as critical drivers of tumor initiation and progression through diverse mechanisms (6–8). For example, the BCRABL1 fusion in chronic myeloid leukemia encodes a constitutively active tyrosine kinase, while the EML4-ALK fusion in non-small cell lung cancer (NSCLC) activates oncogenic signaling cascades (9, 10). Beyond protein-coding chRNAs, non-coding fusion transcripts such as SLC45A3-ELK4 and F-circRNAs like F-circBA1 further exemplify the multifaceted roles of fusion gene products in promoting proliferation, metastasis, and therapy resistance (11, 12). Despit","cbCaikJc3mZXfEcD","https://ap.wps.com/l/cbCaikJc3mZXfEcD","pdf",14093447,17,"English","# Oncogenic fusion RNAs and the knowledge gap\n## Identified transcripts from the KANSL1-ARL17A fusion\n## Functional effects in vitro and in vivo\n## Synergistic regulation via the F-circKA/miR-6860/chKANSARL axis\n## Biological background on lung cancer and fusion-gene mechanisms","[{\"question\":\"What fusion-derived RNAs were identified in this study?\",\"answer\":\"The study identifies a lung cancer-specific chimeric RNA, chKANSARL, and a circular variant, F-circKA, both derived from the KANSL1-ARL17A fusion gene.\"},{\"question\":\"How do chKANSARL and F-circKA affect lung cancer cells?\",\"answer\":\"Overexpression of either transcript enhances lung cancer cell proliferation, migration, and invasion, while knockdown suppresses these malignant phenotypes.\"},{\"question\":\"What mechanism links F-circKA to chKANSARL expression?\",\"answer\":\"miRNA sequencing and dual-luciferase assays show that F-circKA acts as a sponge for miR-6860, derepressing chKANSARL expression; inhibiting miR-6860 reverses the tumor-suppressive effect of F-circKA knockdown.\"}]","The KANSL1-ARL17A fusion gene generates oncogenic chKANSARL and F-circKA RNAs that synergistically drive lung cancer progression via a novel F-circKA/miR-6860/chKANSARL axis - Research article | PDF",1790115970,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3adfd5e3c2adef9581852471f76c3ef.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b4f567ef66f089d85dc18ab01643859.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3b2ce9ac2e738c2472abc3b28d09272.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33033cc9a91cfc0f0ff69afc651dab29.webp",980,1292]